Published in COPD on October 01, 2009
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest (2013) 2.71
Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab (2004) 2.47
Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.97
Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med (2003) 1.93
Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.91
Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr (2010) 1.91
The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med (2005) 1.85
Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD. COPD (2009) 1.79
Indicator dilution measurements of extravascular lung water: basic assumptions and observations. Am J Physiol Lung Cell Mol Physiol (2008) 1.74
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
A treadmill ramp protocol using simultaneous changes in speed and grade. Med Sci Sports Exerc (2003) 1.69
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med (2014) 1.68
Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab (2003) 1.57
Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc (2007) 1.56
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab (2002) 1.54
Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients. Kidney Int (2005) 1.51
Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48
Exhaled breath condensates: analyzing the expiratory plume. Am J Respir Crit Care Med (2012) 1.45
Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest (2002) 1.45
Counterpoint: Is an increase in FEV₁ and/or FVC ≥ 12% of control and ≥ 200 mL the best way to assess positive bronchodilator response? No. Chest (2014) 1.42
Sinusoidal high-intensity exercise does not elicit ventilatory limitation in chronic obstructive pulmonary disease. Exp Physiol (2013) 1.41
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med (2011) 1.41
Physiologic effects of an ambulatory ventilation system in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.39
Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab (2005) 1.28
Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects. J Appl Physiol (1985) (2005) 1.25
Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol (2007) 1.21
Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest (2005) 1.19
Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant (2005) 1.19
Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med (2010) 1.13
Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med (2011) 1.12
Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients. J Appl Physiol (1985) (2011) 1.04
Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chron Obstruct Pulmon Dis (2008) 1.01
An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med (2015) 1.00
Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr Opin Pulm Med (2005) 0.97
Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol (1985) (2007) 0.95
Assessment of exhaled breath condensate pH. Am J Respir Crit Care Med (2011) 0.94
Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Ann Nutr Metab (2013) 0.91
Pulmonary rehabilitation: WHAT WE KNOW AND WHAT WE NEED TO KNOW. J Cardiopulm Rehabil Prev (2009) 0.89
Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Ren Nutr (2006) 0.89
Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest (2002) 0.87
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin Infect Dis (2012) 0.86
Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.84
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. COPD (2011) 0.83
Comment on 'the effect of temperature on exhaled breath condensate collection'. J Breath Res (2012) 0.82
Breath-by-breath quantification of progressive airflow limitation during exercise in COPD: a new method. Respir Med (2010) 0.81
Reduction of hyperinflation by pharmacologic and other interventions. Proc Am Thorac Soc (2006) 0.81
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD (2012) 0.81
Testosterone and resistance training effects on muscle nitric oxide synthase isoforms in COPD men. Respir Med (2011) 0.80
Pulmonary rehabilitation for COPD. Respir Med (2005) 0.79
Supervised high intensity continuous and interval training vs. self-paced training in COPD. Respir Med (2007) 0.78
Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients. BMC Pulm Med (2014) 0.78
Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2014) 0.78
Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcomes. COPD (2005) 0.78
Mitochondrial disorders and exertional intolerance: controversy continues. Am J Respir Crit Care Med (2002) 0.77
Clarifying the equation for modeling of VO2 kinetics above the lactate threshold. J Appl Physiol (1985) (2010) 0.76
The mechanism of the exercise hyperpnea: the ultrasecret revisited. Am J Respir Crit Care Med (2012) 0.76
Why conventional exhaled breath condensate pH studies cannot provide reliable estimates of airway acidification. Chest (2011) 0.75
Getting serious about strength training. J Cardiopulm Rehabil (2006) 0.75
Limitation to exercise tolerance in chronic obstructive pulmonary disease: look to the muscles of ambulation. Am J Respir Crit Care Med (2003) 0.75
COPD therapeutics: picking the low-hanging fruit. COPD (2006) 0.75
Assessing the dose of supplemental oxygen: let us compare methodologies. Respir Care (2005) 0.75
Selecting constant work rates for endurance testing in COPD: the role of the power-duration relationship. COPD (2013) 0.75
Rebuttal from Drs Hansen and Porszasz. Chest (2014) 0.75
Noninvasive assessment of normality of VD/VT in clinical cardiopulmonary exercise testing utilizing incremental cycle ergometry. Eur J Appl Physiol (2012) 0.75
In reference to Continuous laryngoscopy exercise test: a method for visualizing laryngeal dysfunction during exercise. Laryngoscope (2007) 0.75
Is exercise important in chronic obstructive pulmonary disease? COPD (2007) 0.75
Pulmonary rehabilitation and clinical trial design in patients with severe COPD. COPD (2008) 0.75
Cardiopulmonary exercise testing: does it improve perioperative care and outcome? Curr Opin Anaesthesiol (2012) 0.75
Severe exercise-induced hypoxemia. Respir Care (2012) 0.75